Published in Behav Ther on May 31, 2007
Distress tolerance and psychopathological symptoms and disorders: a review of the empirical literature among adults. Psychol Bull (2010) 2.28
Stressful life events and adherence in HIV. AIDS Patient Care STDS (2008) 1.51
Overload: impact of incident stressful events on antiretroviral medication adherence and virologic failure in a longitudinal, multisite human immunodeficiency virus cohort study. Psychosom Med (2009) 1.30
Do positive psychosocial factors predict disease progression in HIV-1? A review of the evidence. Psychosom Med (2008) 1.27
Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis. Curr HIV/AIDS Rep (2014) 1.23
View of God as benevolent and forgiving or punishing and judgmental predicts HIV disease progression. J Behav Med (2011) 1.12
Functional impairment and health care utilization among HIV-infected men who have sex with men: the relationship with depression and post-traumatic stress. J Behav Med (2009) 1.12
Negative urgency, distress tolerance, and substance abuse among college students. Addict Behav (2012) 1.07
Affective correlates of stimulant use and adherence to anti-retroviral therapy among HIV-positive methamphetamine users. AIDS Behav (2009) 0.97
Posttraumatic stress and marijuana use coping motives: the mediating role of distress tolerance. J Anxiety Disord (2010) 0.92
Domain-general and domain-specific strategies for the assessment of distress intolerance. Psychol Addict Behav (2011) 0.92
Optimizing the effects of stress management interventions in HIV. Health Psychol (2008) 0.90
Life events, coping, and antihypertensive medication adherence among older adults: the cohort study of medication adherence among older adults. Am J Epidemiol (2012) 0.88
OPRM1 and diagnosis-related posttraumatic stress disorder in binge-drinking patients living with HIV. AIDS Behav (2012) 0.87
Refining the measurement of distress intolerance. Behav Ther (2011) 0.87
Rumination Mediates the Relationship Between Distress Tolerance and Depressive Symptoms Among Substance Users. Cognit Ther Res (2013) 0.86
Evaluating emotional sensitivity and tolerance factors in the prediction of panic-relevant responding to a biological challenge. J Anxiety Disord (2010) 0.85
Distress tolerance and use of antiretroviral therapy among HIV-infected individuals in substance abuse treatment. AIDS Patient Care STDS (2013) 0.82
Predictors of dropout from psychosocial treatment in opioid-dependent outpatients. Am J Addict (2013) 0.82
Future directions for interventions targeting PTSD in HIV-infected adults. J Assoc Nurses AIDS Care (2014) 0.79
Distress intolerance and clinical functioning in persons with schizophrenia. Psychiatry Res (2014) 0.77
Dynamic indices of methamphetamine dependence and HIV infection predict fluctuations in affective distress: a five-year longitudinal analysis. J Affect Disord (2013) 0.76
Can behavioral theory inform the understanding of depression and medication nonadherence among HIV-positive substance users? J Behav Med (2014) 0.75
The role of distress intolerance in the relationship between childhood sexual abuse and problematic alcohol use among Latin American MSM. Drug Alcohol Depend (2017) 0.75
Transdiagnostic emotional vulnerabilities linking obsessive-compulsive and depressive symptoms in a community-based sample of adolescents. Depress Anxiety (2017) 0.75
The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol (1986) 124.55
Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol (1989) 14.72
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS (2000) 8.86
Assessing the impact of life changes: development of the Life Experiences Survey. J Consult Clin Psychol (1978) 6.76
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA (2000) 6.49
Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA (2001) 5.52
Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis (2001) 5.43
Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol (2000) 4.73
Distress tolerance and duration of past smoking cessation attempts. J Abnorm Psychol (2002) 4.52
Impact of HIV-related stigma on health behaviors and psychological adjustment among HIV-positive men and women. AIDS Behav (2006) 4.34
Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS (2002) 3.45
Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring. Behav Res Ther (2001) 2.95
Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med (2005) 2.83
Progression to AIDS: the effects of stress, depressive symptoms, and social support. Psychosom Med (1999) 2.36
Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors. Psychol Med (2002) 2.34
Barriers to antiretroviral adherence: the importance of depression, abuse, and other traumatic events. AIDS Patient Care STDS (2006) 2.30
HIV disease progression: depression, stress, and possible mechanisms. Biol Psychiatry (2003) 2.22
Continued high-risk sex among HIV seropositive gay and bisexual men seeking HIV prevention services. Health Psychol (1997) 2.07
Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr (2006) 2.01
The role of anxiety sensitivity in the pathogenesis of panic: prospective evaluation of spontaneous panic attacks during acute stress. J Abnorm Psychol (1997) 1.98
How trauma, recent stressful events, and PTSD affect functional health status and health utilization in HIV-infected patients in the south. Psychosom Med (2005) 1.98
Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosom Med (2006) 1.88
Prospective evaluation of anxiety sensitivity in the pathogenesis of panic: replication and extension. J Abnorm Psychol (1999) 1.84
Psychological distress among minority and low-income women living with HIV. Behav Med (2002) 1.71
Prospective study of depression and the risk of heavy alcohol use in women. Am J Psychiatry (2000) 1.69
Psychosocial predictors of risky sexual behaviors in African American men: implications for prevention. AIDS Educ Prev (2003) 1.69
Recovery of the immune system with antiretroviral therapy: the end of opportunism? JAMA (1998) 1.68
Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death. Int J STD AIDS (2004) 1.61
Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation. Psychol Med (1997) 1.52
Stressful life events and symptom onset in HIV infection. Am J Psychiatry (1991) 1.50
Natural history of neuropsychiatric manifestations of HIV disease. Psychiatr Clin North Am (1994) 1.43
Sexual risk, substance use, and psychological distress in HIV-positive gay and bisexual men who also inject drugs. AIDS (2005) 1.36
Relationship of psychosocial factors to HIV disease progression. Ann Behav Med (1996) 1.24
Distress, denial, and low adherence to behavioral interventions predict faster disease progression in gay men infected with human immunodeficiency virus. Int J Behav Med (1994) 1.23
Predictors of sexual transmission risk behaviors among HIV-positive young men. AIDS Care (2005) 1.13
Contextual factors and other correlates of sexual risk of HIV among African-American crack-abusing women. Addict Behav (2003) 1.09
Psychological distress, drug and alcohol use as correlates of condom use in HIV-serodiscordant heterosexual couples. AIDS (1993) 1.06
Effects of AIDS-related bereavement on HIV progression among New York City gay men. AIDS Educ Prev (1995) 1.05
Perceived stress mediates the effects of coping on the quality of life of HIV-positive women on highly active antiretroviral therapy. AIDS Behav (2004) 1.03
Outpatient pharmacy care and HIV viral load response among patients on HAART. AIDS Care (2004) 1.03
Stress-related growth among women living with HIV/AIDS: examination of an explanatory model. J Behav Med (2005) 1.03
Stress and depressive symptoms prospectively predict immune change among HIV-seropositive men. HIV Neurobehavioral Research Center Group. Psychiatry (1995) 1.01
Emotional expression and depth processing of trauma and their relation to long-term survival in patients with HIV/AIDS. J Psychosom Res (2003) 1.01
The impact of PTSD on pain experience in persons with HIV/AIDS. Pain (2002) 0.96
Medication adherence strategies for drug abusers with HIV/AIDS. AIDS Care (1998) 0.95
Psychosocial predictors of HIV/STI risk behaviours in a sample of homosexual men. Sex Transm Infect (2003) 0.93
Psychosocial factors and clinical evolution in HIV-1 infection: a longitudinal study. J Psychosom Res (1993) 0.92
Coping and psychological distress among symptomatic HIV+ men who have sex with men. Ann Behav Med (2003) 0.92
AIDS-related grief and coping with loss among HIV-positive men and women. J Behav Med (2003) 0.91
Behavioural inhibition, anxious symptoms, and depressive symptoms: a short-term prospective examination of a diathesis-stress model. Behav Res Ther (2005) 0.78
Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry (2005) 4.81
Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry (2008) 3.64
Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry (2006) 2.77
A short social support measure for patients recovering from myocardial infarction: the ENRICHD Social Support Inventory. J Cardiopulm Rehabil (2003) 2.72
A meta-analysis of the efficacy of acceptance and commitment therapy for clinically relevant mental and physical health problems. Psychother Psychosom (2014) 2.41
The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity. Psychosom Med (2002) 2.22
Stress and health: psychological, behavioral, and biological determinants. Annu Rev Clin Psychol (2005) 2.19
Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychol (2004) 1.97
D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder. Am J Psychiatry (2013) 1.94
Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosom Med (2006) 1.88
Conscientiousness predicts disease progression (CD4 number and viral load) in people living with HIV. Health Psychol (2007) 1.58
Spirituality, religion, and clinical outcomes in patients recovering from an acute myocardial infarction. Psychosom Med (2007) 1.56
A stress and coping model of medication adherence and viral load in HIV-positive men and women on highly active antiretroviral therapy (HAART). Health Psychol (2005) 1.55
Stressful life events and adherence in HIV. AIDS Patient Care STDS (2008) 1.51
Reductions in depressed mood and denial coping during cognitive behavioral stress management with HIV-Positive gay men treated with HAART. Ann Behav Med (2006) 1.29
To take or not to take: decision-making about antiretroviral treatment in people living with HIV/AIDS. AIDS Patient Care STDS (2006) 1.24
Let's get physical: a contemporary review of the anxiolytic effects of exercise for anxiety and its disorders. Depress Anxiety (2013) 1.21
Cognitive-behavioral interventions improve quality of life in women with AIDS. J Psychosom Res (2003) 1.17
Cognitive-behavioral therapy for obsessive-compulsive disorder: a meta-analysis of treatment outcome and moderators. J Psychiatr Res (2012) 1.16
Cognitive-behavioral therapy for the treatment of anxiety disorders. J Clin Psychiatry (2004) 1.15
A path model of the effects of spirituality on depressive symptoms and 24-h urinary-free cortisol in HIV-positive persons. J Psychosom Res (2006) 1.14
Breast cancer patients have improved immune and neuroendocrine functions following massage therapy. J Psychosom Res (2004) 1.14
Stress management and immune system reconstitution in symptomatic HIV-infected gay men over time: effects on transitional naive T cells (CD4(+)CD45RA(+)CD29(+)). Am J Psychiatry (2002) 1.13
Increases in a marker of immune system reconstitution are predated by decreases in 24-h urinary cortisol output and depressed mood during a 10-week stress management intervention in symptomatic HIV-infected men. J Psychosom Res (2005) 1.10
"It's my body'': does patient involvement in decision making reduce decisional conflict? Med Decis Making (2007) 1.07
Augmentation of exposure therapy with post-session administration of D-cycloserine. J Psychiatr Res (2012) 1.06
The effect of a psychosocial intervention and quality of life after acute myocardial infarction: the Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial. J Cardiopulm Rehabil (2006) 1.05
Anxiety sensitivity and marijuana use: an analysis from ecological momentary assessment. Depress Anxiety (2011) 1.04
Cognitive enhancers for anxiety disorders. Pharmacol Biochem Behav (2010) 1.04
Enhancing the health of women living with HIV: the SMART/EST Women's Project. Int J Womens Health (2011) 1.04
Perceived stress mediates the effects of coping on the quality of life of HIV-positive women on highly active antiretroviral therapy. AIDS Behav (2004) 1.03
Improving dietary habits in disadvantaged women with HIV/AIDS: the SMART/EST women's project. AIDS Behav (2006) 1.03
Emotional expression and depth processing of trauma and their relation to long-term survival in patients with HIV/AIDS. J Psychosom Res (2003) 1.01
Life stress and cervical squamous intraepithelial lesions in women with human papillomavirus and human immunodeficiency virus. Psychosom Med (2003) 1.01
Is it Beneficial to Add Pharmacotherapy to Cognitive-Behavioral Therapy when Treating Anxiety Disorders? A Meta-Analytic Review. Int J Cogn Ther (2009) 0.99
Smoking Behavior and Alcohol Consumption in Individuals With Panic Attacks. J Cogn Psychother (2011) 0.99
Social Support Mediates Loneliness and Human Herpesvirus Type 6 (HHV-6) Antibody Titers. J Appl Soc Psychol (2006) 0.99
Panic attack history and anxiety sensitivity in relation to cognitive-based smoking processes among treatment-seeking daily smokers. Nicotine Tob Res (2012) 0.98
Natural killer cells and lymphocytes increase in women with breast cancer following massage therapy. Int J Neurosci (2005) 0.98
Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. J Consult Clin Psychol (2004) 0.97
People living with HIV: sources of information on antiretroviral treatment and preferences for involvement in treatment decision-making. Eur J Med Res (2007) 0.97
Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentation. J Anxiety Disord (2009) 0.96
Psychosocial responses to treatment for breast cancer among lesbian and heterosexual women. Women Health (2006) 0.96
Fear activation and distraction during the emotional processing of claustrophobic fear. J Behav Ther Exp Psychiatry (2004) 0.95
Behavioral versus cognitive treatment of obsessive-compulsive disorder: an examination of outcome and mediators of change. J Consult Clin Psychol (2013) 0.94
Exploring exercise as an avenue for the treatment of anxiety disorders. Expert Rev Neurother (2012) 0.94
Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome. Behav Brain Funct (2010) 0.94
Social anxiety disorder in DSM-5. Depress Anxiety (2014) 0.92
Sleep disturbance mediates the association between psychological distress and immune status among HIV-positive men and women on combination antiretroviral therapy. J Psychosom Res (2003) 0.92
Coping and psychological distress among symptomatic HIV+ men who have sex with men. Ann Behav Med (2003) 0.92
Associations Between Fear of Negative Evaluation and Eating Pathology During Intervention and 12-Month Follow-up. Cognit Ther Res (2013) 0.92
Pitfalls of meta-analyses. J Nerv Ment Dis (2008) 0.91
Everything changed: spiritual transformation in people with HIV. Int J Psychiatry Med (2009) 0.91
The effect of attributional processes concerning medication taking on return of fear. J Consult Clin Psychol (2008) 0.90
Spiritual and mind-body beliefs as barriers and motivators to HIV-treatment decision-making and medication adherence? A qualitative study. AIDS Patient Care STDS (2009) 0.90
Extinction retention predicts improvement in social anxiety symptoms following exposure therapy. Depress Anxiety (2009) 0.89
Emotional responding to hyperventilation as a predictor of agoraphobia status among individuals suffering from panic disorder. J Behav Ther Exp Psychiatry (2003) 0.89
Empirically supported treatments for panic disorder. Psychiatr Clin North Am (2009) 0.88
Differential sensitivity of the three ASI factors in predicting panic disorder patients' subjective and behavioral response to hyperventilation challenge. J Anxiety Disord (2003) 0.87
Attention training to reduce attention bias and social stressor reactivity: an attempt to replicate and extend previous findings. Behav Res Ther (2012) 0.86
Examination of the decline in fear and disgust during exposure to threat-relevant stimuli in blood-injection-injury phobia. J Anxiety Disord (2006) 0.86
Urinary dopamine and turn bias in traumatized women with and without PTSD symptoms. Behav Brain Res (2003) 0.86
Changes in anxiety sensitivity with pharmacotherapy for panic disorder. J Psychiatr Res (2004) 0.85
The effect of exercise training modality on serum brain derived neurotrophic factor levels in individuals with type 2 diabetes. PLoS One (2012) 0.85
Unexpected arousal, anxiety sensitivity, and their interaction on CO₂-induced panic: further evidence for the context-sensitivity vulnerability model. J Anxiety Disord (2011) 0.85
Stress as a predictor of symptomatic genital herpes virus recurrence in women with human immunodeficiency virus. J Psychosom Res (2003) 0.84
Effects of D-cycloserine administration on weekly nonemotional memory tasks in healthy participants. Psychother Psychosom (2008) 0.84
Specificity of disgust vulnerability in the distinction and treatment of OCD. J Psychiatr Res (2011) 0.84
Written emotional disclosure and processing of trauma are associated with protected health status and immunity in people living with HIV/AIDS. Br J Health Psychol (2008) 0.84
Longitudinal spiritual coping with trauma in people with HIV: implications for health care. AIDS Patient Care STDS (2014) 0.83
Sleep quality predicts treatment outcome in CBT for social anxiety disorder. Depress Anxiety (2013) 0.83
Physical activity as a moderator of the association between anxiety sensitivity and binge eating. Eat Behav (2012) 0.83
An investigation of the relationship between fear of negative evaluation and bulimic psychopathology. Eat Behav (2010) 0.83
The Protective Role of the Family and Social Support Network in a Sample of HIV-Positive African American Women: Results of a Pilot Study. J Black Psychol (2003) 0.83
Do conversations with virtual avatars increase feelings of social anxiety? J Anxiety Disord (2013) 0.83
Measuring the involvement of people with HIV in treatment decision making using the control preferences scale. Med Decis Making (2008) 0.82
Prescriptive variables for d-cycloserine augmentation of exposure therapy for posttraumatic stress disorder. J Psychiatr Res (2013) 0.82
Concurrent associations between anxiety sensitivity and perceived health and health disability among young adult daily smokers. Cogn Behav Ther (2007) 0.82
Exercise Augmentation of Exposure Therapy for PTSD: Rationale and Pilot Efficacy Data. Cogn Behav Ther (2015) 0.82
Five sessions and counting: considering ultra-brief treatment for panic disorder. Depress Anxiety (2012) 0.81
Negative affect as a mediator of the relationship between vigorous-intensity exercise and smoking. Addict Behav (2010) 0.81
Smoking Status and Exercise in relation to PTSD Symptoms: A Test among Trauma-Exposed Adults. Ment Health Phys Act (2013) 0.81
Evaluative conditioning of fear and disgust in blood-injection-injury phobia: specificity and impact of individual differences in disgust sensitivity. J Anxiety Disord (2008) 0.80
Mediation of symptom changes during inpatient treatment for eating disorders: the role of obsessive-compulsive features. J Psychiatr Res (2010) 0.80
Update on the efficacy of pharmacotherapy for social anxiety disorder: a meta-analysis. Expert Opin Pharmacother (2014) 0.79
Spiritual coping predicts CD4-cell preservation and undetectable viral load over four years. AIDS Care (2014) 0.79
Exercise for mood and anxiety disorders. Prim Care Companion J Clin Psychiatry (2007) 0.78
Anxiety, Substance Use, and Their Co-Occurrence: Advances in Clinical Science. J Cogn Psychother (2011) 0.78
Enhancing exposure therapy for PTSD with yohimbine HCL: protocol for a double-blind, randomized controlled study implementing subjective and objective measures of treatment outcome. Contemp Clin Trials (2013) 0.78
Appraisal of social concerns: a cognitive assessment instrument for social phobia. Depress Anxiety (2004) 0.78
The relative contributions of fear and disgust reductions to improvements in spider phobia following exposure-based treatment. J Behav Ther Exp Psychiatry (2010) 0.78
Exercise for mood and anxiety disorders. J Clin Psychiatry (2007) 0.78
Examination of the decline in symptoms of anxiety and depression in generalized anxiety disorder: impact of anxiety sensitivity on response to pharmacotherapy. Depress Anxiety (2008) 0.78
Effects of threat context and cardiac sensitivity on fear responding to a 35% CO2 challenge: a test of the context-sensitivity panic vulnerability model. J Behav Ther Exp Psychiatry (2010) 0.77
Health locus of control beliefs and healthy survival with AIDS. Int J Behav Med (2012) 0.77
Active-imaginal exposure: examination of a new behavioral treatment for cynophobia (dog phobia). Behav Res Ther (2003) 0.77
Exercise for Mood and Anxiety Disorders: The State-of-the Science. Cogn Behav Ther (2015) 0.77
Evaluation of the glycine transporter inhibitor Org 25935 as augmentation to cognitive-behavioral therapy for panic disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychiatry (2012) 0.77
Exercise and coping-oriented alcohol use among a trauma-exposed sample. Addict Behav (2010) 0.77
Benevolent Images of God, Gratitude, and Physical Health Status. J Relig Health (2015) 0.77